Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07151586 | Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer(ALTER) | not yet recruiting | Phase 2 | 260 | UNICANCEROTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07728565 | Long-term Evaluation of Quality of Life and Aesthetic Outcomes After Autologous Breast Reconstruction Using the Profunda Artery Perforator (PAP) Flap(QUALIPAP) | not yet recruiting | — | 264 | Assistance Publique - Hôpitaux de Paris |
| 1 |
| Aug 3, 2026 |
| clinicaltrials |
| NCT07742969 | The Effect of Dyadic Self-Care Education Provided to Breast Cancer Patient-Caregiver Dyads on Patient and Caregiver Outcomes | not yet recruiting | N/A | 156 | Ulviye Aydan NACAKOTHER | 0 | Aug 3, 2026 | clinicaltrials |
| NCT07294430 | Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.(OASISImmunoPET) | not yet recruiting | Phase 2 | 30 | UNICANCEROTHER | 0 | Jul 31, 2026 | clinicaltrials |
| NCT07735897 | Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women(ASTRRAIV) | not yet recruiting | — | 1,483 | MedicalExcellenceOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT07738341 | GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ) | not yet recruiting | Phase 1 / Phase 2 | 270 | Eddingpharm (Zhuhai) Co., Ltd.INDUSTRY | 0 | Jul 31, 2026 | clinicaltrials |
| NCT07737132 | Comparison of Postoperative Analgesic Efficacy of Two Different Blocks in Modified Radical Mastectomy Surgery(mastectomy) | not yet recruiting | N/A | 70 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 0 | Jul 30, 2026 | clinicaltrials |
| NCT07232056 | Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy(GOAL-AI) | not yet recruiting | N/A | 452 | Duke UniversityOTHER | 0 | Jul 29, 2026 | clinicaltrials |
| NCT07732686 | Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry | not yet recruiting | — | 2,000 | University of OklahomaOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT07732101 | Exercise Intervention for Breast Cancer Patients With Sarcopenia(EX-BCSarc) | not yet recruiting | N/A | 104 | Capital Medical UniversityOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT07729046 | Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer | not yet recruiting | Phase 2 | 150 | University of California, San DiegoOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT07458113 | Sac-TMT for Active TNBC Brain Metastases(BERLIN) | not yet recruiting | Phase 2 | 20 | Yale UniversityOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07724769 | De-escalation of RNI in Breast Cancer Patients With pN0 After Neoadjuvant Therapy(OMIT-RNI) | not yet recruiting | N/A | 100 | Aya Ahmed SayedOTHER | 0 | Jul 24, 2026 | clinicaltrials |
| NCT07726342 | SMP-656 for HER2-Positive Advanced Breast Cancer | not yet recruiting | Phase 2 | 60 | Chengdu SciMount Pharmatech Co., Ltd.INDUSTRY | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07606287 | Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital | not yet recruiting | N/A | 4,000 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07683754 | T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd(DB-Guide) | not yet recruiting | Phase 3 | 200 | Daiichi SankyoINDUSTRY | 0 | Jul 23, 2026 | clinicaltrials |
| NCT07721259 | A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden | not yet recruiting | Phase 2 | 60 | University of WashingtonOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07722156 | The Effect of Channa Striata and Curcuma Supplementation on Nutritional Status, Interleukin-6 Levels, and Quality of Life in Patients With Breast Cancer.(CCBreast) | not yet recruiting | N/A | 76 | DINA KEUMALA SARIOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07718841 | neoAGORA: Exploring Clinical Utility of Serial Liquid Biopsy (ctDNA) in Patients With Early-Stage Breast Cancer(neoAGORA) | not yet recruiting | — | 300 | Spanish Breast Cancer Research GroupOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07719634 | Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma(mua) | not yet recruiting | N/A | 45 | Assiut UniversityOTHER | 0 | Jul 22, 2026 | clinicaltrials |
| NCT07186491 | Wearable Ultrasound Patch for Breast Imaging | not yet recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07490509 | Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer(DOSABEMA) | not yet recruiting | Phase 4 | 235 | Poitiers University HospitalOTHER | 0 | Jul 21, 2026 | clinicaltrials |
| NCT07716046 | Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer(FACET) | not yet recruiting | Phase 2 | 240 | Fudan UniversityOTHER | 0 | Jul 21, 2026 | clinicaltrials |
| NCT07716306 | Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer | not yet recruiting | N/A | 60 | Riga Stradins UniversityOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07717450 | Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.(TAILORswitch) | not yet recruiting | Phase 3 | 370 | UNICANCEROTHER | 0 | Jul 21, 2026 | clinicaltrials |
| NCT07706842 | Ataraxis Real-World Clinical Outcomes Registry Linking AI-Based Pathology Scores to Patient Outcomes(ARC) | not yet recruiting | — | 1,000 | Ataraxis AI, Inc.INDUSTRY | 0 | Jul 16, 2026 | clinicaltrials |
| NCT07706933 | Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast Cancer | not yet recruiting | N/A | 456 | Henan Cancer HospitalOTHER_GOV | 0 | Jul 16, 2026 | clinicaltrials |
| NCT07705074 | FAPI PET Imaging - An Exploratory Study(FAPIPET) | not yet recruiting | Phase 1 / Phase 2 | 770 | Martin HuellnerOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT07701018 | Advancing Patient Care for Lymphatic Pain and Lymphedema | not yet recruiting | N/A | 35 | University of Missouri, Kansas CityOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT07701070 | SHIELD: Surveillance of HR+/HER2- : Implementing ESR1m Long-term Monitoring and Detection in 1L aBC(SHIELD) | not yet recruiting | — | 3,000 | AstraZenecaINDUSTRY | 0 | Jul 14, 2026 | clinicaltrials |
| NCT07701941 | A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 220 | Daiichi SankyoINDUSTRY | 0 | Jul 14, 2026 | clinicaltrials |
| NCT05326165 | Early Intervention | not yet recruiting | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07695948 | Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer Survivors | not yet recruiting | Phase 3 | 252 | University of Illinois at ChicagoOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07697443 | Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects | not yet recruiting | Phase 1 / Phase 2 | 306 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07681297 | Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease(TIBEC) | not yet recruiting | Phase 1 / Phase 2 | 154 | National University Hospital, SingaporeOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT07696754 | Augmented-Reality ICG Fluorescence Second-Look for Residual Nodal Disease After Axillary Dissection in Breast Cancer(AR4SLN) | not yet recruiting | N/A | 30 | Ss. Cyril and Methodius University of SkopjeOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT07689721 | ctDNA-Guided Intraventricular Therapy for CNS Malignancies(GUIDE-CNS) | not yet recruiting | N/A | 77 | Alireza MansouriOTHER | 0 | Jul 8, 2026 | clinicaltrials |
| NCT07689929 | Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy | not yet recruiting | — | 900 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT07691333 | Kumorixilib Plus Capecitabine and Letrozole for Neoadjuvant Treatment of HR-Positive HER2-Negative Breast Cancer | not yet recruiting | Phase 2 | 35 | Fujian Cancer HospitalOTHER_GOV | 1 | Jul 8, 2026 | clinicaltrials |
| NCT07687225 | Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases(POSITIVE-Bone) | not yet recruiting | N/A | 216 | West China HospitalOTHER | 0 | Jul 7, 2026 | clinicaltrials |
| NCT07683572 | Device Validation of Augmented-Reality ICG Fluorescence Imaging for Sentinel Lymph Node Detection in Breast Cancer | not yet recruiting | — | 200 | Ss. Cyril and Methodius University of SkopjeOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07684456 | Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer | not yet recruiting | Phase 3 | 308 | Beijing Biostar Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07671937 | INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study(INSPIRE) | not yet recruiting | N/A | 2,748 | University of Alabama at BirminghamOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07229378 | Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer | not yet recruiting | N/A | 40 | University of FloridaOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07670754 | ORASIS in Breast Reconstruction | not yet recruiting | N/A | 30 | Duke UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07677956 | Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer | not yet recruiting | — | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Jul 1, 2026 | clinicaltrials |
| NCT07676344 | CRYO-TOUCH: Cryoablation of the Primary Breast Tumor in Metastatic Breast Cancer(CRYO-TOUCH) | not yet recruiting | N/A | 42 | Hospices Civils de LyonOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07676591 | EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors(EmpowerHer) | not yet recruiting | N/A | 147 | University of ValenciaOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07676812 | The Effect of Animation Video and Training Booklet Designed on Breast Cancer(Breast Cancer) | not yet recruiting | N/A | 128 | Istanbul UniversityOTHER | 0 | Jun 30, 2026 | clinicaltrials |
| NCT07677436 | Effect of Virtual Reality-Guided Imagery on Pain, Anxiety, and Fatigue in Cancer Patients Undergoing Chemotherapy(VRGI-Chemo Tri) | not yet recruiting | N/A | 108 | Thoalfokar Mohammed Al-ObaidiOTHER | 1 | Jun 30, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 3, 2026source: clinicaltrials